BioRestorative Therapies, Inc.
Biotechnology company · Melville, New York, United States
BioRestorative Therapies, Inc. is a biotechnology company headquartered in Melville, New York, United States. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $513,160 in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $1.4 million sold in a notice filed in 2025.
BioRestorative Therapies at a glance
What does BioRestorative Therapies do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $513,160 in total (2021 to 2022). NIH funding came from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Child Health and Human Development.
Private fundraising reported to the SEC
10 Form D notices; the most recent reported $1.4 million sold (2025).
Frequently asked questions about BioRestorative Therapies
Where is BioRestorative Therapies headquartered?
BioRestorative Therapies, Inc. is headquartered in Melville, New York, United States.
What does BioRestorative Therapies do?
BioRestorative Therapies, Inc. is a biotechnology company.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.